L. Becker Hewes - 05 Jan 2026 Form 4 Insider Report for Galecto, Inc. (GLTO)

Reporting relationship: Chief Medical Officer
Issuer ticker: GLTO
Reported as of: 05 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jan 2026, 19:34:03 UTC
Prior SEC filing: 21 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Lori Firmani, attorney-in-fact

Key filing fact

L. Becker Hewes filed Form 4 for Galecto, Inc. (GLTO) on 07 Jan 2026.

Key facts

This page summarizes L. Becker Hewes's Form 4 filing for Galecto, Inc. (GLTO).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jan 2026, 19:34.

Change

Previous filing in this sequence was filed on 21 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001840110 Primary reporting owner

Hewes L. Becker

Relationship: Chief Medical Officer
Address: C/O GALECTO, INC.,, 221 CRESCENT ST, BUILDING 23, SUITE 105, WALTHAM
Signature: /s/ Lori Firmani, attorney-in-fact
Signature date: 07 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLTO transaction

Common Stock

Award

Transaction value: $0
Shares: +264,629
Change %
Price: $0.000000
Shares after: 264,629
Date: 05 Jan 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLTO transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +528,603
Change %
Price: $0.000000
Shares after: 528,603
Date: 05 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 528,603
Exercise price: $21.82
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer. The RSUs will vest with respect to 25% on each anniversary of the grant date through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Footnote F2

This option represents a right to purchase shares of common stock of the Issuer. This option will vest as to 25% on January 5, 2027 and in equal monthly installments thereafter through January 5, 2030, subject to the Reporting Person's continued service to the Issuer on each such vesting date.